Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Juan, PR
NPI
1225325574
Since 2011
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
655 Calle Europa, Edificio Chinea, Oficina 201
San Juan, PR, 00909
Phone (787) 727-8295
Groups this clinician bills Medicare through
Medicare paid, 2024
$28K
380 services
Medicare patients, 2024
136
Average age 74
Drug cost, 2024
$3.9M
14,418 prescriptions
Company payments, 2025
$755
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dalitza M Alvarez Valentin was code 99214 (office e&m - established), 167 times for 70 patients. In total Dalitza M Alvarez Valentin billed 380 services in 9 codes, and Medicare paid $28K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 167 | 70 | $92.36 | $15K |
| 99213 Office E&M - Established | Office | 138 | 68 | $66.93 | $9,236 |
By year: 2022 $20K for 267 services; 2023 $24K for 318 services; 2024 $28K for 380 services.
Medicare prescription drug claims, 2024
In 2024, the drug Dalitza M Alvarez Valentin prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 1,766 prescriptions and refills. In total Dalitza M Alvarez Valentin wrote 14,418 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 1,766 | 4,251 | 520 | $189K |
| Rosuvastatin Calcium Generic | 1,466 | 3,972 | 581 | $26K |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 994 | 1,500 | 236 | $910K |
| Atorvastatin Calcium Generic | 843 | 2,328 | 344 | $11K |
| Metformin Hcl Er Metformin Hcl | 741 | 2,081 | 302 | $12K |
| Glipizide Generic | 638 | 1,792 | 242 | $14K |
| Levothyroxine Sodium Generic | 590 | 1,580 | 206 | $10K |
| Metformin Hcl Generic | 438 | 1,208 | 189 | $4,101 |
| Ozempic Semaglutide | 436 | 490 | 66 | $470K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 396 | 622 | 100 | $376K |
| Gabapentin Generic | 376 | 1,014 | 145 | $5,283 |
| Mounjaro Tirzepatide | 366 | 366 | 46 | $390K |
| Alendronate Sodium Generic | 323 | 750 | 113 | $3,876 |
| Glyxambi Empagliflozin/Linagliptin | 281 | 390 | 66 | $238K |
| Glimepiride Generic | 268 | 694 | 94 | $4,235 |
Brand drugs: 6,571 claims; generic drugs: 7,257 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dalitza M Alvarez Valentin $755 ($755 in general payments such as food, travel and fees) from 10 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $264.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $264 |
| Bayer Puerto Rico Inc. BAYN.DE | 5 | $122 |
| Abbott Laboratories ABT | 5 | $96.47 |
| Novo Nordisk Inc NVO | 3 | $73.9 |
| Radius Health, Inc. | 3 | $65.74 |
| Amgen Inc. AMGN | 2 | $48.51 |
| Lilly USA, LLC LLY | 1 | $25 |
| Abbvie Inc. ABBV | 1 | $25 |
| Dexcom, Inc. DXCM | 1 | $20 |
| Eli Lilly Export S.A. Puerto Rico Branch LLY | 1 | $15.51 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.